Semaglutide and Type 2 Diabetes Contact Hours: 2 Author(s): Maureen Sullivan-Tevault RN, BSN, CEN, CDCES Course Highlights In this course, you will learn about the mechanisms and clinical applications of GLP-1 injectable medications, specifically semaglutide, in managing Type 2 diabetes and its associated health risks
[8] Hydration status: Gastrointestinal side effects such as vomiting and diarrhoea increase the risk of dehydration, which is a well-recognised contributor to fatigue
Efficacy and Personalized Care: Clinical trials show significant weight loss, with many patients losing over 15% of their initial weight
"We've taken those normal signaling molecules in your body and we've turned them into medicines," Skovronsky said
However, when compared to insulin, GLP-1 RAs provided protection against advanced-stage DR